Hemab
Kathryn Zwetchkenbaum currently serves as the Manager of HR, Office, and Executive Assistant to the CEO at Hemab Therapeutics since May 2023. Prior to this, Kathryn held multiple positions at Relay Therapeutics from April 2019 to November 2022, including Executive Assistant to the Development Organization, Executive Assistant to the Chief Executive Officer, Executive Assistant and Project Coordinator, and Office Manager. Kathryn's experience in retail includes roles at J.Crew from October 2014 to January 2019, serving as Store Director, Associate Store Manager, and Keyholder. An internship at The Healthy Holiday Company occurred in 2014, along with sales support at J.Crew in 2012. Kathryn holds a Bachelor's degree with Honours in Vocal Performance from The Royal Conservatoire of Scotland and a Bachelor's degree in Vocal Performance from The Cleveland Institute of Music.
This person is not in any offices
Hemab
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.